The Second Affiliated Hospital of Shaanxi University of Chinese Medicine
Welcome,         Profile    Billing    Logout  
 5 Trials 
5 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zheng, Wei
NCT05042375: A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer

Recruiting
3
450
RoW
camrelizumab + famitinib, pembrolizumab, camrelizumab
Jiangsu HengRui Medicine Co., Ltd.
Non-small Cell Lung Cancer
12/23
12/25
NCT06301854: Long-term Safety of TPN171H Tablet in Erectile Dysfunction.

Recruiting
3
472
RoW
TPN171H, Simmerafil
Vigonvita Life Sciences
Erectile Dysfunction
04/25
04/25
NCT06498479: ARTEMIS-008:HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer

Recruiting
3
460
RoW
HS-20093, Topotecan
Hansoh BioMedical R&D Company
Small Cell Lung Cancer
09/26
05/27
NCT06143735: A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors

Not yet recruiting
2
99
RoW
Efgbemalenograstim alfa
Tianjin Medical University Cancer Institute and Hospital, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Non Small Cell Lung Cancer
12/24
06/26
Li, Tianhao
NCT06697886: A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold

Recruiting
3
480
RoW
Antiwei Granules, Antiwei Granules Placebo
Tasly Pharmaceutical Group Co., Ltd
Common Cold
06/25
07/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zheng, Wei
NCT05042375: A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer

Recruiting
3
450
RoW
camrelizumab + famitinib, pembrolizumab, camrelizumab
Jiangsu HengRui Medicine Co., Ltd.
Non-small Cell Lung Cancer
12/23
12/25
NCT06301854: Long-term Safety of TPN171H Tablet in Erectile Dysfunction.

Recruiting
3
472
RoW
TPN171H, Simmerafil
Vigonvita Life Sciences
Erectile Dysfunction
04/25
04/25
NCT06498479: ARTEMIS-008:HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer

Recruiting
3
460
RoW
HS-20093, Topotecan
Hansoh BioMedical R&D Company
Small Cell Lung Cancer
09/26
05/27
NCT06143735: A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors

Not yet recruiting
2
99
RoW
Efgbemalenograstim alfa
Tianjin Medical University Cancer Institute and Hospital, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Non Small Cell Lung Cancer
12/24
06/26
Li, Tianhao
NCT06697886: A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold

Recruiting
3
480
RoW
Antiwei Granules, Antiwei Granules Placebo
Tasly Pharmaceutical Group Co., Ltd
Common Cold
06/25
07/25

Download Options